Home
CLPT
CLPT News

Latest ClearPoint Neuro Inc. (CLPT) News on June 2, 2025

ClearPoint Neuro First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

17 days ago

ClearPoint Neuro First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

ClearPoint Neuro Inc (CLPT) Q1 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges

GuruFocus.com

19 days ago

ClearPoint Neuro Inc (CLPT) Q1 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges

ACCESS Newswire

20 days ago

ClearPoint Neuro Reports First Quarter 2025 Results

ACCESS Newswire

21 days ago

ClearPoint Neuro Announces Investment of up to $110 Million by Oberland Capital with $33.5 Million Funded at Closing

ClearPoint Neuro Inc (CLPT) Q1 2025 Earnings Report Preview: What to Look For

GuruFocus.com

21 days ago

ClearPoint Neuro Inc (CLPT) Q1 2025 Earnings Report Preview: What to Look For

ACCESS Newswire

a month ago

ClearPoint Neuro, Together with its Partner Clinical Laserthermia Systems, Announces FDA Submission to Expand the Labeling of ClearPoint Prism(R) to Include 1.5 T MRI

The five-year returns have been incredible for ClearPoint Neuro (NASDAQ:CLPT) shareholders despite underlying losses increasing

Simply Wall St.

a month ago

The five-year returns have been incredible for ClearPoint Neuro (NASDAQ:CLPT) shareholders despite underlying losses increasing

ACCESS Newswire

a month ago

ClearPoint Neuro to Announce First Quarter 2025 Results May 13, 2025

ACCESS Newswire

a month ago

ClearPoint Neuro Announces Full Market Release of ClearPoint Navigation Software Version 3.0 - Delivering the First End-to-End ClearPoint Navigation Solution to the Operating Room

Here's Why We're Not Too Worried About ClearPoint Neuro's (NASDAQ:CLPT) Cash Burn Situation

Simply Wall St.

2 months ago

Here's Why We're Not Too Worried About ClearPoint Neuro's (NASDAQ:CLPT) Cash Burn Situation

ClearPoint Neuro Full Year 2024 Earnings: Misses Expectations

Simply Wall St.

3 months ago

ClearPoint Neuro Full Year 2024 Earnings: Misses Expectations

ClearPoint Neuro, Inc. (NASDAQ:CLPT) Analysts Are Pretty Bullish On The Stock After Recent Results

Simply Wall St.

3 months ago

ClearPoint Neuro, Inc. (NASDAQ:CLPT) Analysts Are Pretty Bullish On The Stock After Recent Results

ACCESS Newswire

3 months ago

ClearPoint Neuro Reports Fourth Quarter and Full Year 2024 Results

ClearPoint Neuro Inc (CLPT) Q4 2024: Everything You Need To Know Ahead Of Earnings

GuruFocus.com

3 months ago

ClearPoint Neuro Inc (CLPT) Q4 2024: Everything You Need To Know Ahead Of Earnings

While institutions own 33% of ClearPoint Neuro, Inc. (NASDAQ:CLPT), individual investors are its largest shareholders with 59% ownership

Simply Wall St.

3 months ago

While institutions own 33% of ClearPoint Neuro, Inc. (NASDAQ:CLPT), individual investors are its largest shareholders with 59% ownership

ACCESS Newswire

4 months ago

ClearPoint Neuro to Announce Fourth Quarter and Full Year 2024 Results February 26, 2025

ACCESS Newswire

4 months ago

ClearPoint Neuro Announces EU MDR Certification for the SmartFlow Cannula

ClearPoint Neuro price target raised to $20 from $15 at B. Riley

TipRanks

4 months ago

ClearPoint Neuro price target raised to $20 from $15 at B. Riley

ClearPoint Neuro, Inc. (CLPT): A Bull Case Theory

Insider Monkey

4 months ago

ClearPoint Neuro, Inc. (CLPT): A Bull Case Theory

ACCESS Newswire

4 months ago

ClearPoint Neuro Announces FDA Clearance for ClearPoint Navigation Software Version 3.0

ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain

ACCESSWIRE

7 months ago

ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain

The ClearPoint Neuro, Inc. (NASDAQ:CLPT) Third-Quarter Results Are Out And Analysts Have Published New Forecasts

Simply Wall St.

7 months ago

The ClearPoint Neuro, Inc. (NASDAQ:CLPT) Third-Quarter Results Are Out And Analysts Have Published New Forecasts

ACCESSWIRE

7 months ago

ClearPoint Neuro Reports Third Quarter 2024 Results

ClearPoint Neuro Inc (CLPT) Q3 2024 Earnings Report Preview: What To Expect

GuruFocus.com

7 months ago

ClearPoint Neuro Inc (CLPT) Q3 2024 Earnings Report Preview: What To Expect

Those who invested in ClearPoint Neuro (NASDAQ:CLPT) five years ago are up 213%

Simply Wall St.

7 months ago

Those who invested in ClearPoint Neuro (NASDAQ:CLPT) five years ago are up 213%

ACCESSWIRE

7 months ago

ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2024

ClearPoint Neuro to Announce Third Quarter 2024 Results November 7, 2024

GlobeNewswire

8 months ago

ClearPoint Neuro to Announce Third Quarter 2024 Results November 7, 2024

ClearPoint Neuro Announces Early Repayment of $10 Million Note

GlobeNewswire

9 months ago

ClearPoint Neuro Announces Early Repayment of $10 Million Note

ClearPoint Neuro Reports Second Quarter 2024 Results

GlobeNewswire

10 months ago

ClearPoint Neuro Reports Second Quarter 2024 Results

ClearPoint Neuro to Announce Second Quarter 2024 Results August 7, 2024

GlobeNewswire

a year ago

ClearPoint Neuro to Announce Second Quarter 2024 Results August 7, 2024

ClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint® Navigation System for All Enrolled Patients in ASPIRO Clinical Trial

GlobeNewswire

a year ago

ClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint® Navigation System for All Enrolled Patients in ASPIRO Clinical Trial

Parkinson's Disease Clinical Trial Uses Intraoperative MRI to Guide Precision Implantation of Patients' Own Autologous Replacement Neurons

PR Newswire

a year ago

Parkinson's Disease Clinical Trial Uses Intraoperative MRI to Guide Precision Implantation of Patients' Own Autologous Replacement Neurons

ClearPoint Neuro Announces Full Market Release of SmartFrame OR™ and ClearPoint PRISM® 3T Laser Therapy System

GlobeNewswire

a year ago

ClearPoint Neuro Announces Full Market Release of SmartFrame OR™ and ClearPoint PRISM® 3T Laser Therapy System

GuruFocus.com

a year ago

ClearPoint Neuro Inc (CLPT) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue Growth ...

ClearPoint Neuro Reports First Quarter 2024 Results

GlobeNewswire

a year ago

ClearPoint Neuro Reports First Quarter 2024 Results

ClearPoint Neuro to Present Novel Research and Exhibit at the 27th American Society of Gene & Cell Therapy Annual Meeting in Baltimore

GlobeNewswire

a year ago

ClearPoint Neuro to Present Novel Research and Exhibit at the 27th American Society of Gene & Cell Therapy Annual Meeting in Baltimore

ClearPoint Neuro Announces FDA Clearance of Prism Bone Anchor Accessory

GlobeNewswire

a year ago

ClearPoint Neuro Announces FDA Clearance of Prism Bone Anchor Accessory

ClearPoint Neuro Announces Initiation of Limited Market Release for the SmartFrame OR™ Stereotactic System

GlobeNewswire

a year ago

ClearPoint Neuro Announces Initiation of Limited Market Release for the SmartFrame OR™ Stereotactic System

ClearPoint Neuro to Announce First Quarter 2024 Results May 7, 2024

GlobeNewswire

a year ago

ClearPoint Neuro to Announce First Quarter 2024 Results May 7, 2024

Is There Now An Opportunity In ClearPoint Neuro, Inc. (NASDAQ:CLPT)?

Simply Wall St.

a year ago

Is There Now An Opportunity In ClearPoint Neuro, Inc. (NASDAQ:CLPT)?

ClearPoint Neuro Congratulates its Partner AviadoBio on First Patient Treated in its ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations

GlobeNewswire

a year ago

ClearPoint Neuro Congratulates its Partner AviadoBio on First Patient Treated in its ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations

ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza™ as a Treatment for AADC Deficiency

GlobeNewswire

a year ago

ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza™ as a Treatment for AADC Deficiency

ClearPoint Neuro, Inc. (NASDAQ:CLPT) Annual Results: Here's What Analysts Are Forecasting For This Year

Simply Wall St.

a year ago

ClearPoint Neuro, Inc. (NASDAQ:CLPT) Annual Results: Here's What Analysts Are Forecasting For This Year

ClearPoint Neuro Full Year 2023 Earnings: Beats Expectations

Simply Wall St.

a year ago

ClearPoint Neuro Full Year 2023 Earnings: Beats Expectations

GuruFocus.com

a year ago

ClearPoint Neuro Inc Reports Robust Revenue Growth in Q4 and Full-Year 2023

ClearPoint Neuro Reports Fourth Quarter and Full-Year 2023 Results

GlobeNewswire

a year ago

ClearPoint Neuro Reports Fourth Quarter and Full-Year 2023 Results

Journal of Neurosurgery Publication Demonstrates Distinct Advantages of ClearPoint Prism® Neuro Laser Therapy System

GlobeNewswire

a year ago

Journal of Neurosurgery Publication Demonstrates Distinct Advantages of ClearPoint Prism® Neuro Laser Therapy System

ClearPoint Neuro to Announce Fourth Quarter and Full Year 2023 Results March 12, 2024

GlobeNewswire

a year ago

ClearPoint Neuro to Announce Fourth Quarter and Full Year 2023 Results March 12, 2024

ClearPoint Neuro Announces Pricing of Public Offering of 2,307,694 Shares of Common Stock

GlobeNewswire

a year ago

ClearPoint Neuro Announces Pricing of Public Offering of 2,307,694 Shares of Common Stock

ClearPoint Neuro Launches Proposed Public Offering of Common Stock

GlobeNewswire

a year ago

ClearPoint Neuro Launches Proposed Public Offering of Common Stock

ClearPoint Neuro Announces FDA Clearance and First-in-Human Cases Performed with the New 2.2 Software Version and the Integrated Maestro Brain Model

GlobeNewswire

a year ago

ClearPoint Neuro Announces FDA Clearance and First-in-Human Cases Performed with the New 2.2 Software Version and the Integrated Maestro Brain Model

ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 2024 ASCO Genitourinary Cancers Symposium

CNW Group

a year ago

ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 2024 ASCO Genitourinary Cancers Symposium

ClearPoint Neuro Announces Installation and First Procedure Using the ClearPoint Prism® Neuro Laser Therapy System and Navigation System at Kaleida Health in Buffalo

GlobeNewswire

a year ago

ClearPoint Neuro Announces Installation and First Procedure Using the ClearPoint Prism® Neuro Laser Therapy System and Navigation System at Kaleida Health in Buffalo

ClearPoint Neuro Announces First EU MDR Certification Success and Approval to Ship Product to Europe

GlobeNewswire

a year ago

ClearPoint Neuro Announces First EU MDR Certification Success and Approval to Ship Product to Europe

Adams Diversified Equity Fund Announces 2023 Performance

GlobeNewswire

a year ago

Adams Diversified Equity Fund Announces 2023 Performance

Adams Diversified Equity Fund Declares Distribution

GlobeNewswire

a year ago

Adams Diversified Equity Fund Declares Distribution

VIZSLA SILVER TO SPIN OUT NET SMELTER ROYALTY TO SHAREHOLDERS

CNW Group

a year ago

VIZSLA SILVER TO SPIN OUT NET SMELTER ROYALTY TO SHAREHOLDERS

Nanox Mourns Death of Its Founder, Ran Poliakine

GlobeNewswire

a year ago

Nanox Mourns Death of Its Founder, Ran Poliakine

ClearPoint Neuro Announces FDA Clearance for SmartFrame OR™ Stereotactic System

GlobeNewswire

a year ago

ClearPoint Neuro Announces FDA Clearance for SmartFrame OR™ Stereotactic System

L.B. Foster's (NASDAQ:FSTR) investors will be pleased with their respectable 93% return over the last year

Simply Wall St.

a year ago

L.B. Foster's (NASDAQ:FSTR) investors will be pleased with their respectable 93% return over the last year

Associated Press Finance

a year ago

Concrete Pumping: Fiscal Q4 Earnings Snapshot

Concrete Pumping Holdings Reports Strong Fourth Quarter and Fiscal Year 2023 Results, Provides Financial Outlook for Fiscal Year 2024

GlobeNewswire

a year ago

Concrete Pumping Holdings Reports Strong Fourth Quarter and Fiscal Year 2023 Results, Provides Financial Outlook for Fiscal Year 2024

Similarweb Reveals 100 Digital Businesses That Achieved Outstanding Growth in 2023

Business Wire

a year ago

Similarweb Reveals 100 Digital Businesses That Achieved Outstanding Growth in 2023

Akoya Biosciences Announces that Garry Nolan, Ph.D., James Allison, Ph.D., and Padmanee Sharma, M.D., Ph.D., Join Newly Created Scientific Advisory Board

GlobeNewswire

a year ago

Akoya Biosciences Announces that Garry Nolan, Ph.D., James Allison, Ph.D., and Padmanee Sharma, M.D., Ph.D., Join Newly Created Scientific Advisory Board

Rackspace Technology Elevates Database Management with Rackspace Cloud Database Ops for AWS

GlobeNewswire

a year ago

Rackspace Technology Elevates Database Management with Rackspace Cloud Database Ops for AWS

ClearPoint Neuro Reports Fourth Quarter and Full Year 2023 Preliminary Revenue Results and Guidance for Full Year 2024 Revenue

GlobeNewswire

a year ago

ClearPoint Neuro Reports Fourth Quarter and Full Year 2023 Preliminary Revenue Results and Guidance for Full Year 2024 Revenue

Thornburg Income Builder Opportunities Trust Announces Distribution

PR Newswire

a year ago

Thornburg Income Builder Opportunities Trust Announces Distribution

Unity Bancorp (NASDAQ:UNTY) shareholders have earned a 21% CAGR over the last three years

Simply Wall St.

a year ago

Unity Bancorp (NASDAQ:UNTY) shareholders have earned a 21% CAGR over the last three years

Calavo Growers Insiders Placed Bullish Bets Worth US$4.98m

Simply Wall St.

a year ago

Calavo Growers Insiders Placed Bullish Bets Worth US$4.98m

Sharecare to present at 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

a year ago

Sharecare to present at 42nd Annual J.P. Morgan Healthcare Conference

While insiders own 32% of Backblaze, Inc. (NASDAQ:BLZE), retail investors are its largest shareholders with 37% ownership

Simply Wall St.

a year ago

While insiders own 32% of Backblaze, Inc. (NASDAQ:BLZE), retail investors are its largest shareholders with 37% ownership

We're Keeping An Eye On Shattuck Labs' (NASDAQ:STTK) Cash Burn Rate

Simply Wall St.

a year ago

We're Keeping An Eye On Shattuck Labs' (NASDAQ:STTK) Cash Burn Rate

Invivyd (IVVD) Surges on Positive Data From COVID-19 Study

Zacks

a year ago

Invivyd (IVVD) Surges on Positive Data From COVID-19 Study

Those who invested in ClearPoint Neuro (NASDAQ:CLPT) five years ago are up 365%

Simply Wall St.

a year ago

Those who invested in ClearPoint Neuro (NASDAQ:CLPT) five years ago are up 365%

Skeena Closes C$81 Million Financing with Franco-Nevada

ACCESSWIRE

a year ago

Skeena Closes C$81 Million Financing with Franco-Nevada

Julie Casteel Wins Stevie® Award for Women in Business

GlobeNewswire

a year ago

Julie Casteel Wins Stevie® Award for Women in Business

Is There Now An Opportunity In Entravision Communications Corporation (NYSE:EVC)?

Simply Wall St.

a year ago

Is There Now An Opportunity In Entravision Communications Corporation (NYSE:EVC)?

11 Best Water Stocks To Buy

Insider Monkey

a year ago

11 Best Water Stocks To Buy

Stablewood and GCM Grosvenor Form Joint Venture to fund Single Tenant Net Lease Retail Developments Across the U.S.

GlobeNewswire

2 years ago

Stablewood and GCM Grosvenor Form Joint Venture to fund Single Tenant Net Lease Retail Developments Across the U.S.

Multiple Grammy Award-Winning Artist Luis Miguel Partners with Alignment Health to Champion Living with Confidence

GlobeNewswire

2 years ago

Multiple Grammy Award-Winning Artist Luis Miguel Partners with Alignment Health to Champion Living with Confidence

Alpha Tau to Participate in Sidoti Small-Cap Conference

GlobeNewswire

2 years ago

Alpha Tau to Participate in Sidoti Small-Cap Conference

CITIC Offshore Helicopter and Lilium partner to launch eVTOL Network in China's Greater Bay Area

GlobeNewswire

2 years ago

CITIC Offshore Helicopter and Lilium partner to launch eVTOL Network in China's Greater Bay Area

Are Investors Undervaluing ClearPoint Neuro, Inc. (NASDAQ:CLPT) By 41%?

Simply Wall St.

2 years ago

Are Investors Undervaluing ClearPoint Neuro, Inc. (NASDAQ:CLPT) By 41%?

Akebia Therapeutics to Present at Piper Sandler Healthcare Conference

PR Newswire

2 years ago

Akebia Therapeutics to Present at Piper Sandler Healthcare Conference

One Analyst Just Shaved Their Magic Software Enterprises Ltd. (NASDAQ:MGIC) Forecasts Dramatically

Simply Wall St.

2 years ago

One Analyst Just Shaved Their Magic Software Enterprises Ltd. (NASDAQ:MGIC) Forecasts Dramatically

Associated Press Finance

2 years ago

Magic Software: Q3 Earnings Snapshot

American Coastal Insurance Corporation Reports Financial Results for Its Third Quarter Ended September 30, 2023

Business Wire

2 years ago

American Coastal Insurance Corporation Reports Financial Results for Its Third Quarter Ended September 30, 2023

ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q3 2023 Earnings Call Transcript

ClearPoint Neuro Reports Third Quarter 2023 Results

GlobeNewswire

2 years ago

ClearPoint Neuro Reports Third Quarter 2023 Results

PR Newswire

2 years ago

TrueCar Awards Army Veteran with Brand New Vehicle Through DrivenToDrive Initiative

Red Violet, Inc. (NASDAQ:RDVT) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

Red Violet, Inc. (NASDAQ:RDVT) Q3 2023 Earnings Call Transcript

Amplify Energy Corp. (NYSE:AMPY) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

Amplify Energy Corp. (NYSE:AMPY) Q3 2023 Earnings Call Transcript

ThredUp Inc. (NASDAQ:TDUP) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

ThredUp Inc. (NASDAQ:TDUP) Q3 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

2 years ago

Q3 2023 ThredUp Inc Earnings Call

ThredUp (TDUP) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks

2 years ago

ThredUp (TDUP) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Here's Why We're Watching Fulcrum Therapeutics' (NASDAQ:FULC) Cash Burn Situation

Simply Wall St.

2 years ago

Here's Why We're Watching Fulcrum Therapeutics' (NASDAQ:FULC) Cash Burn Situation

Wall Street Analysts Predict a 33.29% Upside in Berry Petroleum (BRY): Here's What You Should Know

Zacks

2 years ago

Wall Street Analysts Predict a 33.29% Upside in Berry Petroleum (BRY): Here's What You Should Know

Postal Realty Trust, Inc. (NYSE:PSTL) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

Postal Realty Trust, Inc. (NYSE:PSTL) Q3 2023 Earnings Call Transcript

Share on Social Networks: